Table of Contents
Chapter One: Executive Summary
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Trends Affecting the Market
- Market Outlook
Chapter Two: Introduction
- Industry Development
- Generic Drug Industry Evolution
- FDA Regulation
- Development and Approval Process
- Industry Structure
- Product Distribution
- Patent Expirations
Chapter Three: Allergy and Respiratory Drugs
- Product Categories
- Asthma, Bronchodilators and Corticosteroids
- Inhaled Corticosteroids
- Antiasthmatic Agents
- Bronchodilating Agents
- Antihistamines, Decongestants, and Cough Preparations
- Antihistamines
- Decongestants
- Cough Preparations
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter Four: Analgesics, Nonsteroidal Anti-Inflammatory Drugs, and Antirheumatic Drugs
- Product Categories
- Analgesics
- Nonsteroidal Anti-inflammatory Drugs
- Antirheumatics
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter five: Anesthesia Drugs
- Product Categories
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter Six: Anti-Infectives
- Product Categories
- Systemic Anti-Infectives
- Topical Anti-Infectives
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter seven: Cancer Drugs
- Products
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter Eight: Cardiovascular Drugs
- Product Categories
- Positive Inotropic Agents
- Antiadrenergics
- Beta-Adrenergic Blocking Agents
- Vasodilators
- Calcium Channel Blockers
- Angiotensin-Converting Enzyme Inhibitors
- Antiarrhythmics
- Antihyperlipidemic Agents
- Anticoagulants
- Diuretics
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs. World Market
- Competitive Analysis
Chapter Nine: Central Nervous System and Psychotherapeutic Drugs
- Product Categories
- Antidepressants, Stimulants, and Antipsychotics
- Antidepressants
- Stimulants
- Antipsychotics
- Anticonvulsants, Antispasmodics, and Muscle Relaxants
- Anticonvulsants
- Antispasmodics
- Muscle Relaxants
- Parkinsons Disease, Myasthenia Gravis, and Multiple Sclerosis
- Parkinsons Disease
- Myasthenia Gravis
- Multiple Sclerosis
- Sedatives, Hypnotics, and Antianxiety Drugs
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
Chapter Ten: Gastrointestinal Drugs
- Product Categories
- Antidiarrheals
- Antinauseants
- Antispasmodics
- Antiulcer
- Digestants
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs the World Market
- Competitive Analysis
Chapter Eleven: Hormonal Drugs
- Product Categories
- Male and Female Hormones
- Corticosteroids
- Diabetes Drugs
- Thyroid Drugs
- Product News
- Market Size and Forecast
- The World Market
- U.S. vs World Market
- Competitive Analysis
Chapter Twelve: Ophthalmic Drugs
- Product Categories
- Ophthalmic Anti-Infectives
- Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors
- Glaucoma Agents
- Product News
- Market Size and Forecast
- The World Market
- U.S. vs World Market
- Competitive Analysis
Chapter Thirteen: World Market Summary
- Overview
- Total Market Size and Forecast
- Market and Competitive Analysis
Chapter Fourteen: Issues and Trends
- Understanding Hatch-Waxman and Its Shortfalls
- The FDA, Funding and Review Times
- Big Pharma Tactics Defensive and Offensive
- Authorized Generics
- Generic Biologics
- Medicaid Generic Drug Reimbursement Issues
- The Elderly
- Confusion in Generic Drug Names
- Broadening Generic Horizons
- International Generic Drug Issues
- Industry Consolidation
- New Generic Giants
- Patent Issues: Filings and Challenges
- Patent Reform
- Generic Growth: Prescriptions, Approvals, Impact
- Generic Statins Countdown
- Prescription Drug Costs
- Generics Improve Compliance
- Generic Drug Sampling
Chapter Fifteen: Company Profiles
- Industry Structure and Participants
- Actavis Group
- Altana Pharma AG
- Andrx Corporation
- Apotex Group
- Aurobindo Pharma, Ltd
- Barr Laboratories, Inc.
- Bedford Laboratories
- Lannett Company, Inc.
- Mylan Laboratories, Inc.
- Orchid Chemicals and Pharmaceuticals, Ltd.
- Par Pharmaceuticals, Inc.
- Perrigo Company
- PLIVA Pharmaceuticals, Inc.
- Ranbaxy Laboratories, Ltd.
- Roxane Laboratories, Inc.
- Sandoz International, GmbH
- Taro Pharmaceutical Industries Ltd.
- TEVA Pharmaceutical Industries, Ltd.
- Watson Pharmaceuticals, Inc.
- United Research Laboratories and Mutual Pharmaceutical Company
- Zydus Pharmaceuticals, Inc
Appendix: Company Directory
List of Exhibits
Chapter One: Executive Summary
- Table 1-1: Market Suumary: World Market for Prescription Generic Drugs
Revenues by Segment 2000-2010
- Figure 1-1: Market Summary: Trending in the World Market for
Prescription Generic Drugs by Segment 2000-2010
Chapter Two: Introduction
- Figure 2-1: Abbreviated New Drug Application Review Flow Chart
- Table 2-1: Brand Name Companies with Generic Subsidiaries
- Table 2-2: Number of Best Selling Drugs with Patents Expiring in Years
2006-2012 Grouped by Treatment Category
- Table 2-3: Best Selling Prescription Drugs with Expected Patent
Expirations (Year of Expiration, Brand, Manufacturer, Indication, 2004
Revenues) 2006-2012
Chapter Three: Allergy and Respiratory Drugs
- Table 3-1: Prescription Allergy and Respiratory ANDA Approvals, 2005
- Table 3-2: The World Market for Prescription Generic Allergy and
Respiratory Drugs by Type 2000-2010
- Figure 3-1: The World Market for Prescription Generic Allergy and
Respiratory Drugs, Revenues by Type 2000-2010
- Table 3-3: The World Market for Prescription Generic Allergy and
Respiratory Drugs, Market Share by Type 2000-2010
- Table 3-4: The World Market for Prescription Generic Allergy and
Respiratory Drugs, U.S. Revenues and Share 2000-2010
- Figure 3-2: The World Market for Prescription Generic Allergy and
Respiratory Drugs, Displaying U.S. Revenues 2000-2010
- Table 3-5: The World Market for Prescription Generic Allergy and
Respiratory Drugs, Revenues and Market Share by Supplier 2005
- Figure 3-3: The World Market for Prescription Generic Allergy and
Respiratory Drugs, Market Share by Leading Supplier 2005
Chapter Four: Analgesics, Nonsteroidal Anti-Inflammatory Drugs, and
Antirheumatic Drugs
- Table 4-1: Prescription Generic Analgesic, NSAID, and Antirheumatic ANDA
Approvals, 2005
- Table 4-2: The World Market for Prescription Generic Analgesics, NSAIDs
and Antirheumatic Drugs by Type 2000-2010
- Figure 4-1: The World Market for Prescription Generic Analgesics,
NSAIDs, and Antirheumatic Drugs, Revenues by Type 2000-2010
- Table 4-3: The World Market for Prescription Generic Analgesics, NSAIDs,
and Antirheumatic Drugs, Market Share by Type 2000-2010
- Table 4-4: The World Market for Prescription Generic Analgesics, NSAIDs,
and Antirheumatic Drugs, U.S. Revenues and Share 2000-2010
- Figure 4-2: The World Market for Prescription Generic Analgesics,
NSAIDs, and Antirheumatic Drugs Displaying U.S. Revenues 2000-2010
- Table 4-5: The World Market for Prescription Generic Analgesics, NSAIDs,
and Antirheumatic Drugs Revenues and Market Share by Supplier 2005
- Figure 4-3: The World Market for Prescription Generic Analgesics,
NSAIDs, and Antirheumatic Drugs Market Share by Leading Supplier 2005
Chapter Five: Anesthesia Drugs
- Table 5-1: Prescription Generic Anesthesia Drug ANDA Approvals, 2005
- Table 5-2: The World Market for Prescription Generic Anesthesia Drugs
2000-2010
- Figure 5-1: The World Market for Prescription Generic Anesthesia Drugs
Revenues 2000-2010
- Table 5-3: The World Market for Prescription Generic Anesthesia Drugs,
U.S. Revenues and Share 2000-2010
- Figure 5-2: The World Market for Prescription Generic Anesthesia Drugs
Displaying U.S. Revenues 2000-2010
- Table 5-4: The World Market for Prescription Generic Anesthesia Drugs,
Revenues and Market Share by Supplier 2005
- Figure 5-3: The World Market for Prescription Generic Anesthesia Drugs
Market Share by Leading Supplier 2005
CHAPTER Six: Anti-Infectives
- Table 6-1: Prescription Generic Anti-infective Drug ANDA Approvals, 2005
- Table 6-2: The World Market for Prescription Generic Anti-Infective
Drugs by Type 2000-2010
- Figure 6-1: The World Market for Prescription Generic Anti-Infective
Drugs, Revenues by Type 2000-2010
- Table 6-3: The World Market for Prescription Generic Anti-Infective
Drugs, Market Share by Type 2000-2010
- Table 6-4: The World Market for Prescription Generic Anti-Infective
Drugs U.S. Revenues and Share 2000-2010
- Figure 6-2: The World Market for Prescription Generic Anti-Infective
Drugs Displaying U.S. Revenues 2000-2010
- Table 6-5: The World Market for Prescription Generic Anti-Infective
Drugs, Revenues and Market Share by Supplier 2005
- Figure 6-3: The World Market for Prescription Generic Anti-Infective
Drugs Market Share by Leading Supplier 2005
Chapter Seven: Cancer Drugs
- Table 7-1: Prescription Generic Cancer Drug ANDA Approvals 2005
- Table 7-2: The World Market for Prescription Generic Cancer Drugs
2000-2010
- Figure 7-1: The World Market for Prescription Generic Cancer Drugs
Revenues 2000-2010
- Table 7-3: The World Market for Prescription Generic Cancer Drugs, U.S.
Revenues and Share 2000-2010
- Figure 7-2: The World Market for Prescription Generic Cancer Drugs
Displaying U.S. Revenues 2000-2010
- Table 7-4: The World Market for Prescription Generic Cancer Drugs,
Revenues and Market Share by Supplier 2005
- Figure 7-3: The World Market for Prescription Generic Cancer Drugs
Market Share by Leading Supplier 2005
Chapter Eight: Cardiovascular Drugs
- Table 8-1: Prescription Generic Cardiovascular Drug ANDA
- Approvals. 2005
- Table 8-2: The World Market for Prescription Generic Cardiovascular
Drugs by Type 2000-2010
- Figure 8-1: The World Market for Prescription Generic Cardiovascular
Drugs Revenues by Type 2000-2010
- Table 8-3: The World Market for Prescription Generic Cardiovascular
Drugs, Market Share by Type 2000-2010
- Figure 8-2: The World Market for Prescription Generic Cardiovascular
Drugs, Share by Type 2005 and 2010
- Table 8-4: The World Market for Prescription Generic Cardiovascular
Drugs U.S. Revenues and Share 2000-2010
- Figure 8-3: The World Market for Prescription Generic Cardiovascular
Drugs Displaying U.S. Revenues 2000-2010
- Table 8-5: The World Market for Prescription Generic Cardiovascular
Drugs, Revenues and Market Share by Supplier 2005
- Figure 8-4: The World Market for Prescription Generic Cardiovascular
Drugs, Market Share by Leading Supplier 2001
Chapter Nine: Central Nervous System and Psychotherapeutic Drugs
- Table 9-1: Prescription Generic Central Nervous System/Psychotherapeutic
Drug ANDA Approvals 2005
- Table 9-2: The World Market for Prescription Generic Central Nervous
System Drugs by Type 2000-2010
- Figure 9-1: The World Market for Prescription Generic Central Nervous
System Drugs Revenues by Type 2000-2010
- Table 9-3: The World Market for Prescription Generic Central Nervous
System Drugs, Market Share by Type 2000-2010
- Table 9-4: The World Market for Prescription Generic Central Nervous
System Drugs, U.S. Revenues and Share 2000-2010
- Figure 9-2: The World Market for Prescription Generic Central Nervous
System Drugs Displaying U.S. Revenues 2000-2010
- Table 9-5: The World Market for Prescription Generic Central Nervous
System Drugs, Revenues and Market Share by Supplier 2005
- Figure 9-3: The World Market for Prescription Generic Central Nervous
System Drugs, Market Share by Leading Supplier 2005
Chapter Ten: Gastrointestinal Drugs
- Table 10-1: Prescription Generic Gastrointestinal Drug ANDA Approvals 2005
- Table 10-2: The World Market for Prescription Generic Gastrointestinal
Drugs by Type, 2000-2010
- Figure 10-1: The World Market for Prescription Generic Gastrointestinal
Drugs Revenues by Type 2000-2010
- Table 10-3: The World Market for Prescription Generic Gastrointestinal
Drugs, Market Share by Type 2000-2010
- Figure 10-2: The World Market for Prescription Generic Gastrointestinal
Drugs, Share by Type 2005 and 2010
- Table 10-4: The World Market for Prescription Generic Gastrointestinal
Drugs, U.S. Revenues and Share 2000-2010
- Figure 10-3: The World Market for Prescription Generic Gastrointestinal
Drugs, Displaying U.S. Revenues 2000-2010
- Table 10-5: The World Market for Prescription Generic Gastrointestinal
Drugs, Revenues and Market Share by Supplier2005
- Figure 10-4: The World Market for Prescription Generic Gastrointestinal
Drugs, Market Share by Leading Supplier 2005
Chapter Eleven: Hormonal Drugs
- Table 11-1: Prescription Generic Hormone Drug ANDA Approvals 2005
- Table 11-2: The World Market for Prescription Generic Hormone Drugs by
Type 2000-2010
- Figure 11-1: The World Market for Prescription Generic Hormone Drugs
Revenues by Type 2000-2010
- Table 11-3: The World Market for Prescription Generic Hormone Drugs,
Market Share by Type 2000-2010
- Figure 11-2: The World Market for Prescription Generic Hormone Drugs
Share by Type 2005 and 2010
- Table 11-4: The World Market for Prescription Generic Hormone Drugs U.S.
Revenues and Share 2000-2010
- Figure 11-3: The World Market for Prescription Generic Hormone Drugs
Displaying U.S. Revenues 2000-2010
- Table 11-5: The World Market for Prescription Generic Hormone Drugs,
Revenues and Market Share by Supplier 2005
- Figure 11-4: The World Market for Prescription Generic Hormone Drugs
Market Share by Leading Supplier 2005
Chapter Twelve: Ophthalmic Drugs
- Table 12-1: Prescription Generic Ophthalmic Drug ANDA Approvals 2001
- Table 12-2: The World Market for Prescription Generic Ophthalmic Drugs
by Type 2000-2010
- Figure 12-1: The World Market for Prescription Generic Ophthalmic Drugs
Revenues by Type 2000-2010
- Table 12-3: The World Market for Prescription Generic Ophthalmic Drugs,
Market Share by Type 2000-2010
- Table 12-4: The World Market for Prescription Generic Ophthalmic Drugs,
U.S. Revenues and Share 2000-2010
- Figure 12-2: The World Market for Prescription Generic Ophthalmic Drugs
Displaying U.S. Revenues 2000-2010
- Table 12-5: The World Market for Prescription Generic Ophthalmic Drugs,
Revenues and Market Share by Supplier 2005
- Figure 12-3: The World Market for Prescription Generic Ophthalmic Drugs
Market Share by Leading Supplier 2005
Chapter Thirteen: World Market Summary
- Table 13-1: The World Market for Prescription Generic Drugs Revenues by
Segment 2000-2010
- Figure 13-1: The World Market for Prescription Generic Drugs Revenues by
Segment 2000-2010
- Figure 13-2: The World Market for Generic Drugs Market Share by Type
2005 and 2010
- Table 13-3: World Market for Prescription Generic Drugs Revenues and
Segments of Participation by Leading Player 2005
Chapter Fourteen: Issues and Trends
- Table 14-1: Reorganization of Major Japanese Generic Drug Manufacturers
|
Related Report
|
View Cart
